Efficacy and Safety of a 7.5% Icodextrin Peritoneal Dialysis Solution in Once-Daily Long Dwell Exchange
NCT00725517
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
2
Enrollment
OTHER
Sponsor class
Conditions
Chronic Kidney Disease
Peritoneal Dialysis
Interventions
DRUG:
Icodextrin
Sponsor
Shanghai Jiao Tong University School of Medicine